XTX Topco’s Annovis Bio ANVS Stock Holding History

XTX Topco’s Portfolio ANVS Stock Details ANVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-24,580	Closed	-$54.8K	–	4126
2026 Q1	$54.8K	Buy	+24,580	New	+$67.4K	﹤0.01%	3291
2025 Q4	–	Sell	-28,854	Closed	-$59.7K	–	3287
2025 Q3	$59.7K	Buy	+28,854	New	+$72.1K	﹤0.01%	2136
2025 Q1	–	Sell	-11,653	Closed	-$58.6K	–	2377
2024 Q4	$58.6K	Buy	+11,653	New	+$84.3K	﹤0.01%	1872
2024 Q3	–	Sell	-19,907	Closed	-$115K	–	2060
2024 Q2	$115K	Buy	+19,907	New	+$161K	0.01%	1387

Other funds holding ANVS

EAM

Empery Asset Management New York $86.5M AUM

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Tudor Investment Corp Stamford, Connecticut $71.9B AUM 42.37% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

XTX Topco's ANVS Position: Q2 2026 in Review

XTX Topco sold out of Annovis Bio (ANVS) in Q2 2026, closing a stake of 24,580 shares — an estimated $54.8K sold.

XTX Topco first reported a position in ANVS in Q2 2024 and held it in 4 quarters. The position peaked at $115K in Q2 2024. 61 funds tracked by Wall St. Rank hold ANVS as of Q2 2026.

XTX Topco reported no remaining Annovis Bio position as of Q2 2026 after selling out during the quarter.
XTX Topco sold 24,580 Annovis Bio shares in Q2 2026, an estimated $54.8K.
XTX Topco first reported a position in Annovis Bio in Q2 2024 and held it in 4 quarters.
XTX Topco's Annovis Bio position peaked at $115K in Q2 2024.
61 funds tracked by Wall St. Rank held Annovis Bio as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.